CHME vs PFE: Which Stock is Better?
Side-by-side comparison of China Medicine Corporation and Pfizer Inc in 2026
CHME
China Medicine Corporation
$0.02
PFE
Pfizer Inc
$25.55
Key Metrics Comparison
| Metric | CHME | PFE | Winner |
|---|---|---|---|
| Market Cap | $0.47M | $146.08B | PFE |
| P/E Ratio | N/A | 19.56 | PFE |
| EPS (TTM) | $N/A | $1.31 | PFE |
| Revenue Growth | -0.1% | 0.1% | PFE |
| Gross Margin | 33.5% | 74.8% | PFE |
Analyze CHME
Full quant analysis
Analyze PFE
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CHME or PFE a better investment?
Comparing CHME and PFE: China Medicine Corporation has a market cap of $0.47M while Pfizer Inc has $146.08B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CHME and PFE?
CHME (China Medicine Corporation) and PFE (Pfizer Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CHME or PFE?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CHME or PFE?
PFE has higher revenue growth at 0.1% vs -0.1% for CHME.
Which company is more profitable: CHME or PFE?
Pfizer Inc (PFE) has higher gross margins at 74.8% compared to 33.5% for CHME.
Which is the larger company: CHME or PFE?
Pfizer Inc (PFE) is larger with a market cap of $146.08B compared to $0.47M for CHME.
Should I buy CHME or PFE in 2026?
Both CHME and PFE have investment merit. CHME trades at $0.02 while PFE trades at $25.55. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CHME and PFE stock?
Key differences: Market Cap ($0.47M vs $146.08B), P/E Ratio (N/A vs 19.6x), Revenue Growth (-0.1% vs 0.1%), Gross Margin (33.5% vs 74.8%).